| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
1993-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b8690b1d27dc260ac29027fcd00424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c2f5d6c65184c6b7b1139baa2b8075c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd608723899db1eee49ec10606cad4cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beda1f44482b6c4badadcc149934bcf6 |
| publicationDate |
1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5834214-A |
| titleOfInvention |
Detection of pancreatitis-associated protein for screening for cystic fibrosis |
| abstract |
The invention relates to in vitro detection of human pancreatitis-associated protein (hPAP) for the purpose of screening for cystic fibrosis. hPAP is quantitated in a biological sample, preferably blood, and a high value is indicative of pancreatic dysfunction. Immunoassays as rapid, reliable methods for hPAP quantitation are provided as are antibodies for use in the assays and hybridomas for production of monoclonal antibodies preferred for use in the assays. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005043589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6458076-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39062-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39299-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224638-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212000-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03094958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7033317-B2 |
| priorityDate |
1992-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |